Charles River Laboratories International, Inc. (CRL) vs DENTSPLY SIRONA Inc. (XRAY)

CRL leads on 7 of 13 compared metrics.

A side-by-side comparison of Charles River Laboratories International, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — CRL vs XRAY

growth of $100 · last 26y
CRL +752.3%XRAY -3.5%CRL compounded faster
Log scale — wide-divergence pair
101001k10kStart $10020052010201520202025$852$96
CRL XRAY

CRL vs XRAY: by the numbers

  • CRL is the larger company ($9.03B vs $2.02B market cap).
  • Both run net losses; CRL's is the smaller (-4.59% vs -17.06% net margin).
  • CRL grew revenue faster over the past five years (5.77% vs 1.12% CAGR).
  • XRAY pays a dividend (4.76% yield) while CRL does not currently pay one.

Which is better, CRL or XRAY?

Metric tally: CRL 7 · XRAY 6

It depends on what you're optimizing for:

GrowthCRL(faster 5Y revenue CAGR)
QualityCRL(higher ROIC)

Valuation

MetricCRLXRAY
Forward P/E15.217.11
P/S ratio2.280.55
P/B ratio3.121.53
EV / EBITDA41.45
FCF yield4.26%5.16%

Profitability

MetricCRLXRAY
Gross margin31.86%48.93%
Operating margin11.77%5.87%
Net margin-4.59%-17.06%
ROE-6.28%-47.65%
ROIC8.36%5.67%

Dividends

MetricCRLXRAY
Dividend yield4.76%

Growth (annualized)

MetricCRLXRAY
Revenue CAGR (5Y)5.77%1.12%
EPS CAGR (5Y)-40.99%-0.93%
FCF CAGR (5Y)-3.98%-29.96%
Total return CAGR (5Y)-11.83%-29.72%

Frequently asked

Which is better, CRL or XRAY?
It depends on your goal. growth: CRL (faster 5Y revenue CAGR); quality: CRL (higher ROIC). Across all compared metrics, CRL leads 7 to 6.
Which has grown faster, CRL or XRAY?
Over the past five years, CRL grew revenue faster — CRL at a 5.77% CAGR versus XRAY at 1.12%.
Does CRL or XRAY pay a bigger dividend?
XRAY pays a dividend (4.76% yield) while CRL does not currently pay one.
Which has been the better investment, CRL or XRAY?
Over the past 10-year, CRL delivered the higher annualized total return — CRL at 8.26% versus XRAY at -15.61%. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.